Top Markets
#1 ICON ICON +156.44%
#2 ZetaChain ZetaChain +47.92%
#3 Four Four +39.72%
#4 Phala Phala +34.53%
#5 Chia Chia +33.77%
#6 Mubarak Mubarak +32.15%
#7 Nano Nano +27.88%
#8 SODAX SODAX +26.10%
#9 Bitway Bitway +24.95%
#10 PumpMeme PumpMeme +23.83%
Coin of the day
ICON ICON
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Rang in Aktien #827
Zoetis Inc. stands as a global leader in animal health, focusing on the... Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
Aktienkurs
$71.46
Marktkapitalisierung
$29.96B
Veränderung (1 Tag)
-0.04%
Veränderung (1 Jahr)
-51.01%
Land
US
Handel Zoetis Inc. (ZTS)

Kategorie

Healthcare
Gewinn für Zoetis Inc. (ZTS)
Gewinn im Jun 2026 TTM: $3.27B
Laut den aktuellen Finanzberichten von Zoetis Inc. betragen die aktuellen Gewinne des Unternehmens $3.27B. Im Jahr 2024 erzielte das Unternehmen einen Gewinn von $3.13B, eine Steigerung gegenüber dem Gewinn im Jahr 2023, der $2.94B betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Zoetis Inc. von 2009 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
2026 (TTM) $3.27B -2.62%
2025 $3.36B 7.25%
2024 $3.13B 6.71%
2023 $2.94B 10.54%
2022 $2.66B 6.75%
2021 $2.49B 24.65%
2020 $2.00B 10.83%
2019 $1.80B 6.57%
2018 $1.69B 10.82%
2017 $1.53B 24.19%
2016 $1.23B 125.32%
2015 $545.00M -33.54%
2014 $820.00M 18.84%
2013 $690.00M -2.82%
2012 $710.00M 80.20%
2011 $394.00M 121.35%
2010 $178.00M -220.27%
2009 $-148.00M 0.00%
Gewinn ähnlicher Unternehmen oder Konkurrenten
Unternehmen Gewinn Gewinnunterschied Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
$33.59B 926.72%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
$25.20B 670.05%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
$8.70B 165.86%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
$21.39B 553.68%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
$5.95B 81.78%
US